FDA's first AI -focused cGMP warning letter signals new scrutiny for manufacturers
The warning letter cited Purolea Cosmetics Lab for AI -related failures involving manufacturing documentation and quality unit oversight. The ...
Read the original at biospace.com ↗
- Topics
- Manufacturing & RoboticsHealthcareGovernance & Risk Management
- Mentions
- FDA
- Tracked via
- “AI Falures”